Michael S. Kelly

734 total citations
21 papers, 510 citations indexed

About

Michael S. Kelly is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael S. Kelly has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael S. Kelly's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes Treatment and Management (6 papers) and Diabetes Management and Research (3 papers). Michael S. Kelly is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes Treatment and Management (6 papers) and Diabetes Management and Research (3 papers). Michael S. Kelly collaborates with scholars based in United States, Saudi Arabia and Italy. Michael S. Kelly's co-authors include Dave L. Dixon, Roy Brown, John D. Bucheit, Janet Silverstein, Walter R. Cunningham, John C. Henretta, Adrian Tomer, Steven P. Broglio, Michael S. Ferrara and Leo F. Buckley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Pediatric Psychology and Diabetes Obesity and Metabolism.

In The Last Decade

Michael S. Kelly

19 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Kelly United States 9 302 136 100 79 64 21 510
Franziska K. Bishop United States 16 537 1.8× 206 1.5× 112 1.1× 36 0.5× 65 1.0× 39 782
Ryutaro Kaneko Japan 15 208 0.7× 116 0.9× 69 0.7× 88 1.1× 92 1.4× 38 833
G. T. C. Ko China 15 312 1.0× 71 0.5× 114 1.1× 60 0.8× 138 2.2× 23 638
Deborah V. Edidin United States 15 308 1.0× 84 0.6× 69 0.7× 53 0.7× 72 1.1× 21 631
Ian Lawrence United Kingdom 15 496 1.6× 206 1.5× 155 1.6× 64 0.8× 61 1.0× 31 787
Hrafnkell Thordarson Norway 15 457 1.5× 225 1.7× 110 1.1× 23 0.3× 83 1.3× 27 620
M Wallymahmed United Kingdom 18 506 1.7× 73 0.5× 119 1.2× 36 0.5× 57 0.9× 37 706
Jee Hee Yoo South Korea 14 329 1.1× 151 1.1× 60 0.6× 54 0.7× 84 1.3× 28 535
Jean François Yale Canada 7 223 0.7× 47 0.3× 57 0.6× 32 0.4× 29 0.5× 8 375
Xiaoguang Yao China 13 138 0.5× 48 0.4× 194 1.9× 61 0.8× 107 1.7× 42 570

Countries citing papers authored by Michael S. Kelly

Since Specialization
Citations

This map shows the geographic impact of Michael S. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Kelly more than expected).

Fields of papers citing papers by Michael S. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Kelly. The network helps show where Michael S. Kelly may publish in the future.

Co-authorship network of co-authors of Michael S. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Kelly. A scholar is included among the top collaborators of Michael S. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Kelly. Michael S. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Michael S., et al.. (2025). Evaluation of lipid-lowering therapy in patients with elevated lipoprotein(a) levels. Journal of clinical lipidology. 19(4). 819–826.
2.
Kelly, Michael S., et al.. (2024). Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 26(12). 5661–5668. 4 indexed citations
3.
Talasaz, Azita H., Anurag Mehta, Michael S. Kelly, et al.. (2023). Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(10). 1051–1063. 21 indexed citations
4.
Kelly, Michael S., et al.. (2023). Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials. Journal of Cardiovascular Pharmacology. 83(1). 8–15. 1 indexed citations
5.
Mehta, Anurag, Dave L. Dixon, Anum Saeed, et al.. (2023). With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?. Current Cardiology Reports. 25(5). 423–430. 2 indexed citations
6.
Kelly, Michael S.. (2022). An update on dapagliflozin for chronic kidney disease. Drugs of today. 58(2). 69–75. 1 indexed citations
7.
Kelly, Michael S., et al.. (2022). Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature. SHILAP Revista de lepidopterología. 10(1). 13–13. 8 indexed citations
8.
Kelly, Michael S., et al.. (2022). Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(12). 921–928. 18 indexed citations
9.
Kelly, Michael S., et al.. (2021). Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations. Blood Pressure. 30(4). 220–229. 8 indexed citations
10.
Kelly, Michael S., et al.. (2020). PCSK9 Inhibitors in Secondary Prevention—An Opportunity for Personalized Therapy. Journal of Cardiovascular Pharmacology. 75(5). 410–420. 11 indexed citations
11.
Kelly, Michael S., et al.. (2020). Role of Bempedoic Acid in Dyslipidemia Management. Journal of Cardiovascular Pharmacology. 76(4). 376–388. 7 indexed citations
12.
Sisson, Evan M., et al.. (2017). Evolving Role of Non‐Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(2). 164–171. 6 indexed citations
13.
Kelly, Michael S., Craig J. Beavers, John D. Bucheit, Evan M. Sisson, & Dave L. Dixon. (2017). Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL). Journal of clinical lipidology. 11(4). 872–879. 7 indexed citations
14.
Baker, William L., Leo F. Buckley, Michael S. Kelly, et al.. (2017). Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 6(5). 139 indexed citations
15.
Dixon, Dave L., et al.. (2016). Effectiveness of Pharmacist‐Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(2). 230–236. 16 indexed citations
16.
Kelly, Michael S., Joseph J. Saseen, & Joel C. Marrs. (2016). Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60–79 years before and after Eighth Joint National Committee recommendations. Therapeutic Advances in Cardiovascular Disease. 11(2). 63–71.
17.
Kelly, Michael S., et al.. (2014). Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale. Journal of Pharmacy Practice. 29(3). 194–198. 7 indexed citations
18.
Broglio, Steven P., et al.. (2008). Reliable Change of the Sensory Organization Test. Clinical Journal of Sport Medicine. 18(2). 148–154. 63 indexed citations
19.
Kelly, Michael S., Johnny S. Kim, & Cynthia Franklin. (2008). Solution-Focused Brief Therapy in Schools. Oxford University Press eBooks. 23 indexed citations
20.
Kelly, Michael S., et al.. (1992). A Longitudinal Analysis of Adherence and Health Status in Childhood Diabetes. Journal of Pediatric Psychology. 17(5). 537–553. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franziska K. Bishop Breakdown of academic impact, for papers by Ryutaro Kaneko Breakdown of academic impact, for papers by G. T. C. Ko Breakdown of academic impact, for papers by Deborah V. Edidin Breakdown of academic impact, for papers by Ian Lawrence Breakdown of academic impact, for papers by Hrafnkell Thordarson Breakdown of academic impact, for papers by M Wallymahmed Breakdown of academic impact, for papers by Jee Hee Yoo Breakdown of academic impact, for papers by Jean François Yale Breakdown of academic impact, for papers by Xiaoguang Yao
Rankless by CCL
2026